<DOC>
	<DOCNO>NCT02520882</DOCNO>
	<brief_summary>This open-label positron emission tomography/computed tomography ( PET/CT ) study investigate diagnostic performance evaluation efficacy 68Ga-NOTA-Aca-BBN ( 7-14 ) glioma patient . A single dose 111-148 Mega-Becquerel ( MBq ) 68Ga-NOTA-Aca-BBN ( 7-14 ) inject intravenously . Visual semiquantitative method use assess PET/CT image .</brief_summary>
	<brief_title>68Ga-NOTA-Aca-BBN ( 7-14 ) PET/CT Patients With Primary Gliomas</brief_title>
	<detailed_description>Non-invasive image evaluation GRPR expression would great help drug development , patient stratification therapeutic response monitoring . Various GRPR target image probe develop meet purpose . Bombesin ( BBN ) amphibian homolog mammalian gastrin-releasing peptide ( GRP ) . BBN ( 7-14 ) , amino acid sequence Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 , extensively use development molecular probe image gastrin-releasing peptide receptor ( GRPR ) , label various radionuclides . Multiple preclinical study demonstrate receptor-specific accumulation tracer GRPR positive tumor . For interest clinical translation 68Ga-NOTA-Aca-BBN ( 7-14 ) , open-label dynamic whole-body PET/ CT study design investigate safety diagnostic performance 68Ga-NOTA-Aca-BBN ( 7-14 ) patient glioma .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<criteria>Must able provide write informed consent Clinically base magnetic resonance imaging ( MRI ) base suspect newly diagnose primary glioma . The tumor surgically remove histological diagnosis available . Females plan bear child recently childbearing potential； Known severe allergy hypersensitivity IV radiographic contrast； Inability lie still entire imaging time cough , pain , etc . Inability complete need examination due severe claustrophobia , radiation phobia , etc . Concurrent severe and/or uncontrolled and/or unstable medical disease , opinion investigator , may significantly interfere study compliance .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>PET/CT</keyword>
	<keyword>Bombesin</keyword>
	<keyword>gastrin-releasing peptide receptor</keyword>
	<keyword>68Gallium labeling</keyword>
</DOC>